BioTech Medics, Inc. (BMCS) Stock

About BioTech Medics, Inc.

BioTech Medics, Inc. operates as a holding company with a focus on the medical field. The firm manages therapeutic laser clinics that deliver treatment for diverse pain conditions impacting muscles, nerves, bones, and arthritic discomfort. Among its product offerings is SHBAN, an antiseptic sanitizing solution for hands and body. Additionally, the company develops and markets nutritional supplements, including BioBody Balance, a concentrated liquid vitamin, and BioBody Energy Spray, a natural, caffeine- and alcohol-free vitamin energy spray. These nutraceutical products are distributed via general retail channels. Founded in 1997 and headquartered in Southlake, Texas, BioTech Medics maintains laser pain centers across Texas, California, New Mexico, and Florida.

BioTech Medics, Inc. (BMCS) stock trades at $0.00 with a market capitalization of $41071. The stock is valued at a price-to-earnings (P/E) ratio of -13.86, price-to-book of 0.01, price-to-sales of 0.09. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades 100.0% below its 52-week high.

On profitability, BioTech Medics, Inc. generates a return on equity (ROE) of 0.00%, return on capital employed of 0.00%, an operating margin of 0.00%, a net profit margin of -128.51%.

Official website: biotecmedics.com